Multipurpose central venous access in the immunocompromised pediatric patient

Paul Colombani, D. L. Dudgeon, J. R. Buck, D. M. Miller, M. J. Ghory, C. Buckloo, J. A. Haller

Research output: Contribution to journalArticle

Abstract

During a 21-month period, 50 consecutive pediatric oncology patients undergoing bone marrow transplantation and/or cytoreductive chemotherapy had 61 silastic central venous catheters placed to facilitate their therapy. All catheters were used for medications, routine blood sampling, and transfusions, with 45% also used for hyperalimentation and 57% used for bone marrow transplantation. Catheters were utilized during both inpatient and outpatient therapy periods. Total catheter days numbered 8455, an average of 139 days per catheter. Forty-seven catheters (77%) were removed electively or were in place at time of patient death. Seven were removed for mechanical complications (1/1409 catheter days). Four additional episodes of presumed catheter sepsis were managed with antibiotics and did not require catheter removal (40% of septic episodes). One catheter is still in place after 585 days. Complication rates were not influenced by this multiple use protocol. With standardized catheter care and surveillance, multipurpose, long-term central venous access can be safely utilized in the immunosuppressed pediatric patient.

Original languageEnglish (US)
Pages (from-to)38-41
Number of pages4
JournalJournal of Parenteral and Enteral Nutrition
Volume9
Issue number1
StatePublished - 1985

Fingerprint

Immunocompromised Host
catheters
Catheters
Pediatrics
bone marrow transplant
Bone Marrow Transplantation
drug therapy
Central Venous Catheters
therapeutics
blood transfusion
blood sampling
Blood Transfusion
Inpatients
Sepsis
Outpatients
Anti-Bacterial Agents
antibiotics
Drug Therapy
death

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Colombani, P., Dudgeon, D. L., Buck, J. R., Miller, D. M., Ghory, M. J., Buckloo, C., & Haller, J. A. (1985). Multipurpose central venous access in the immunocompromised pediatric patient. Journal of Parenteral and Enteral Nutrition, 9(1), 38-41.

Multipurpose central venous access in the immunocompromised pediatric patient. / Colombani, Paul; Dudgeon, D. L.; Buck, J. R.; Miller, D. M.; Ghory, M. J.; Buckloo, C.; Haller, J. A.

In: Journal of Parenteral and Enteral Nutrition, Vol. 9, No. 1, 1985, p. 38-41.

Research output: Contribution to journalArticle

Colombani, P, Dudgeon, DL, Buck, JR, Miller, DM, Ghory, MJ, Buckloo, C & Haller, JA 1985, 'Multipurpose central venous access in the immunocompromised pediatric patient', Journal of Parenteral and Enteral Nutrition, vol. 9, no. 1, pp. 38-41.
Colombani, Paul ; Dudgeon, D. L. ; Buck, J. R. ; Miller, D. M. ; Ghory, M. J. ; Buckloo, C. ; Haller, J. A. / Multipurpose central venous access in the immunocompromised pediatric patient. In: Journal of Parenteral and Enteral Nutrition. 1985 ; Vol. 9, No. 1. pp. 38-41.
@article{010862bcc8c14fcba3d16e8fdf2460d0,
title = "Multipurpose central venous access in the immunocompromised pediatric patient",
abstract = "During a 21-month period, 50 consecutive pediatric oncology patients undergoing bone marrow transplantation and/or cytoreductive chemotherapy had 61 silastic central venous catheters placed to facilitate their therapy. All catheters were used for medications, routine blood sampling, and transfusions, with 45{\%} also used for hyperalimentation and 57{\%} used for bone marrow transplantation. Catheters were utilized during both inpatient and outpatient therapy periods. Total catheter days numbered 8455, an average of 139 days per catheter. Forty-seven catheters (77{\%}) were removed electively or were in place at time of patient death. Seven were removed for mechanical complications (1/1409 catheter days). Four additional episodes of presumed catheter sepsis were managed with antibiotics and did not require catheter removal (40{\%} of septic episodes). One catheter is still in place after 585 days. Complication rates were not influenced by this multiple use protocol. With standardized catheter care and surveillance, multipurpose, long-term central venous access can be safely utilized in the immunosuppressed pediatric patient.",
author = "Paul Colombani and Dudgeon, {D. L.} and Buck, {J. R.} and Miller, {D. M.} and Ghory, {M. J.} and C. Buckloo and Haller, {J. A.}",
year = "1985",
language = "English (US)",
volume = "9",
pages = "38--41",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Multipurpose central venous access in the immunocompromised pediatric patient

AU - Colombani, Paul

AU - Dudgeon, D. L.

AU - Buck, J. R.

AU - Miller, D. M.

AU - Ghory, M. J.

AU - Buckloo, C.

AU - Haller, J. A.

PY - 1985

Y1 - 1985

N2 - During a 21-month period, 50 consecutive pediatric oncology patients undergoing bone marrow transplantation and/or cytoreductive chemotherapy had 61 silastic central venous catheters placed to facilitate their therapy. All catheters were used for medications, routine blood sampling, and transfusions, with 45% also used for hyperalimentation and 57% used for bone marrow transplantation. Catheters were utilized during both inpatient and outpatient therapy periods. Total catheter days numbered 8455, an average of 139 days per catheter. Forty-seven catheters (77%) were removed electively or were in place at time of patient death. Seven were removed for mechanical complications (1/1409 catheter days). Four additional episodes of presumed catheter sepsis were managed with antibiotics and did not require catheter removal (40% of septic episodes). One catheter is still in place after 585 days. Complication rates were not influenced by this multiple use protocol. With standardized catheter care and surveillance, multipurpose, long-term central venous access can be safely utilized in the immunosuppressed pediatric patient.

AB - During a 21-month period, 50 consecutive pediatric oncology patients undergoing bone marrow transplantation and/or cytoreductive chemotherapy had 61 silastic central venous catheters placed to facilitate their therapy. All catheters were used for medications, routine blood sampling, and transfusions, with 45% also used for hyperalimentation and 57% used for bone marrow transplantation. Catheters were utilized during both inpatient and outpatient therapy periods. Total catheter days numbered 8455, an average of 139 days per catheter. Forty-seven catheters (77%) were removed electively or were in place at time of patient death. Seven were removed for mechanical complications (1/1409 catheter days). Four additional episodes of presumed catheter sepsis were managed with antibiotics and did not require catheter removal (40% of septic episodes). One catheter is still in place after 585 days. Complication rates were not influenced by this multiple use protocol. With standardized catheter care and surveillance, multipurpose, long-term central venous access can be safely utilized in the immunosuppressed pediatric patient.

UR - http://www.scopus.com/inward/record.url?scp=0021990074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021990074&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 38

EP - 41

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 1

ER -